Compass Financial Management’s Thermo Fisher Scientific TMO Stock Holding History

Compass Financial Management’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$8.02K	Buy	+16	New	+$7.68K	﹤0.01%	1099

Other funds holding TMO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Compass Financial Management's TMO Position: Q2 2026 in Review

Compass Financial Management opened a new position in Thermo Fisher Scientific (TMO) in Q2 2026: 16 shares worth $8.02K. The stake represents ﹤0.01% of the portfolio and ranks #1099 among its holdings.

2,508 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

Compass Financial Management held 16 shares of Thermo Fisher Scientific worth $8.02K as of Q2 2026.
Thermo Fisher Scientific was a new Compass Financial Management position in Q2 2026.
Thermo Fisher Scientific made up ﹤0.01% of Compass Financial Management's portfolio in Q2 2026, its #1099 holding.
2,508 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Compass Financial Management's 13F filing for Q2 2026, filed 12 Aug 2026.